Smoldering multiple myeloma

SV Rajkumar, O Landgren… - Blood, The Journal of the …, 2015 - ashpublications.org
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. SMM
is distinguished from monoclonal gammopathy of undetermined significance by a much …

MGUS to myeloma: a mysterious gammopathy of underexplored significance

MV Dhodapkar - Blood, The Journal of the American Society of …, 2016 - ashpublications.org
All cases of multiple myeloma (MM) are preceded by precursor states termed monoclonal
gammopathy of undetermined significance (MGUS) or smoldering myeloma (SMM). Genetic …

[HTML][HTML] Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined …

S Rögnvaldsson, TJ Love, S Thorsteinsdottir… - Blood Cancer …, 2021 - nature.com
Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma
(MM). Population-based screening for MGUS could identify candidates for early treatment in …

[HTML][HTML] Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors

E Backhaus, S Berg, R Andersson, G Ockborn… - BMC infectious …, 2016 - Springer
Background Incidence, manifestations and case-fatality rate (CFR) of invasive
pneumococcal disease (IPD) vary with age and comorbidities. New vaccines, changing age …

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

SY Kristinsson, RM Pfeiffer, M Björkholm… - Blood, The Journal …, 2010 - ashpublications.org
Patients with multiple myeloma (MM) have an increased risk of venous thrombosis.
Interestingly, excess risk of venous thromboembolism has been observed among patients …

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)

S Mailankody, RM Pfeiffer… - Blood, The Journal …, 2011 - ashpublications.org
Using population-based data from Sweden, we identified all multiple myeloma (MM) patients
(n= 8740) and 5652 monoclonal gammopathy of undetermined significance (MGUS) …

[HTML][HTML] The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the …

NWCJ van de Donk, A Palumbo, HE Johnsen… - …, 2014 - ncbi.nlm.nih.gov
Monoclonal gammopathy of undetermined significance is one of the most common pre-
malignant disorders. IgG and IgA monoclonal gammopathy of undetermined significance are …

[HTML][HTML] Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study

SY Kristinsson, M Tang, RM Pfeiffer, M Björkholm… - …, 2012 - ncbi.nlm.nih.gov
No comprehensive evaluation has been made to assess the risk of viral and bacterial
infections among patients with monoclonal gammopathy of undetermined significance …

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study

SY Kristinsson, M Tang, RM Pfeiffer… - Blood, The Journal …, 2010 - ashpublications.org
Patients with multiple myeloma (MM) have an increased risk of fractures. On the basis of
small numbers, patients with monoclonal gammopathy of undetermined significance …

[HTML][HTML] Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population …

AÝ Sigurbergsdóttir, S Rögnvaldsson… - …, 2023 - ncbi.nlm.nih.gov
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic
precursor condition that precedes multiple myeloma and related disorders but has also been …